You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

in complete remission

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rectal Cancer Trial in Taipei (Surgery)

Recruiting
  • Rectal Cancer
  • Surgery
  • Taipei, Taiwan
    Jin-Tung LIANG
Jul 27, 2023

Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

Recruiting
  • Acute Myeloid Leukemia
  • Venclexta 100 MG Oral Tablet
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023

Support and Post-therapeutic Rehabilitation for Complete

Not yet recruiting
  • Non-Metastatic Breast Carcinoma
  • +2 more
    • (no location specified)
    Jul 4, 2022

    Advanced DLBCL, Extra-nodal Involvement, Large Mass, Radiotherapy Trial (6-8 cycles (21 days per cycle) of Standard R-CHOP

    Not yet recruiting
    • Advanced Diffuse Large B-Cell Lymphoma
    • +2 more
    • 6-8 cycles (21 days per cycle) of Standard R-CHOP chemotherapy
    • Radiotherapy beyond standard R-CHOP Chemotherapy
    • (no location specified)
    May 24, 2023

    Chronic GVHD Trial in Sevilla (Regulatory T-cell enriched infusion)

    Recruiting
    • Chronic Graft vs Host Disease
    • Regulatory T-cell enriched infusion
    • Sevilla, Spain
      José Antonio Pérez Simón
    May 20, 2022

    Venetoclax Plasma Concentration and Remission in Acute Myeloid

    Not yet recruiting
    • Adult Acute Myeloid Leukemia
    • Blood sampling for venetoclax drug dosage (venous puncture)
    • (no location specified)
    Sep 13, 2023

    Chronic Leukemia Trial in France (Additional biological samples)

    Active, not recruiting
    • Chronic Leukemia
    • Additional biological samples
    • Besançon, France
    • +3 more
    May 31, 2022

    Multiple Myeloma Trial in Baltimore (biological, drug, other)

    Recruiting
    • Multiple Myeloma
    • GM-CSF vaccine
    • +4 more
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Jan 6, 2022

    Hodgkin Lymphoma Trial in Belgium, Denmark, Netherlands (gemcitabine, cisplatin and tislelizumab)

    Not yet recruiting
    • Hodgkin Lymphoma
    • gemcitabine, cisplatin and tislelizumab
    • Brussels, Belgium
    • +14 more
    Aug 12, 2022

    EUS-FNA, Rectal Cancer, Pathological Complete Remission Trial in GuangZhou (EUS-FNA)

    Completed
    • EUS-FNA
    • +2 more
    • TRUS-FNA
    • GuangZhou, Guangdong, China
      The Sixth Affiliate Hospital of Sun Yat-Sen University
    Aug 29, 2022

    Crohn Disease Trial in Worldwide (Infliximab, Placebo)

    Completed
    • Crohn Disease
    • Aarhus, Aarhus C, Denmark
    • +12 more
    Mar 9, 2022

    Hodgkin Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage II Adult Hodgkin Lymphoma Trial in Rochester (drug, genetic, other)

    Withdrawn
    • Hodgkin Lymphoma
    • +4 more
    • Rochester, Minnesota
      Mayo Clinic
    Nov 28, 2022

    Nasopharyngeal Carcinoma Trial in Shanghai (Radiotherapy, Cisplatin)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Shanghai, Shanghai, China
      Fudan Universtiy Shanghai Cancer Centre
    Jan 7, 2023

    Small Cell Lung Cancer Limited Stage Trial (Prophylactic cranial irradiation, Thoracic radiotherapy, Chemotherapy)

    Not yet recruiting
    • Small Cell Lung Cancer Limited Stage
    • Prophylactic cranial irradiation
    • +2 more
    • (no location specified)
    Dec 14, 2022

    Disorder in Complete Remission in Response to Treatment Trial in Wuhan (Sintilimal Injection)

    Recruiting
    • Disorder in Complete Remission in Response to Treatment
    • Sintilimal Injection
    • Wuhan, Hubei, China
      Renmin Hospital of Wuhan University
    Sep 28, 2022

    Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial (Siremadlin)

    Recruiting
    • Acute Myeloid Leukemia
    • Allogeneic Stem Cell Transplantation
    • Tel Aviv, Israel
    • +2 more
    Jan 23, 2023

    Acute Lymphoid Leukemia, Acute Lymphoblastic Leukemia Trial in Aurora (CD19 Directed CAR T Cell)

    Not yet recruiting
    • Acute Lymphoid Leukemia
    • Acute Lymphoblastic Leukemia
    • CD19 Directed CAR T Cell
    • Aurora, Colorado
      University of Colorado Hospital
    Sep 12, 2022

    Leukemia, Myeloid, Acute Trial in China (CC-486, Placebo)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Hefei, Anhui, China
    • +31 more
    Jan 10, 2023

    AML Trial in Moscow (allo-HSCT)

    Recruiting
    • AML
    • allo-HSCT
    • Moscow, Russian Federation
      National Research Center for Hematology
    Apr 14, 2022

    Acute Lymphoblastic Leukemia (ALL) in Partial Remission, Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid

    Recruiting
    • Acute Lymphoblastic Leukemia (ALL) in Partial Remission
    • +2 more
    • Riyadh, Saudi Arabia
      King Faisal Specialist Hospital & Research Center
    Apr 4, 2022

    Primary CNS Lymphoma Trial in Paris (Rituximab, Methotrexate, Temozolomide)

    Active, not recruiting
    • Primary Central Nervous System Lymphoma
    • Rituximab, Methotrexate, Temozolomide
    • Paris, France
      Groupe Hospitalier Pitie Salpetriere
    Feb 10, 2022

    Acute Myeloid Leukemia, MDS, Transplant-Related Hematologic Malignancy Trial in Milano (Fludarabine, ARA-C, Treosulfan)

    Completed
    • Acute Myeloid Leukemia
    • +2 more
    • Milano, Lombardia, Italy
      Ospedale San Raffaele
    Jul 18, 2022

    Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Allogeneic Stem Cell Transplantation Trial in United States

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Boston, Massachusetts
    • +5 more
    Oct 21, 2022

    Multiple Myeloma Trial in Little Rock (Velcade, Melphalan, Thalidomide)

    Active, not recruiting
    • Multiple Myeloma
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences
    Sep 7, 2021

    CT-based Radiomics of ALN pCR in Breast Cancer Undergoing NAC

    Recruiting
    • Triple-negative Breast Cancer
    • HER2-positive Breast Cancer
      • Beijing, Beijing, China
        Peking University Cancer Hospital
      Apr 14, 2022